2-Aminothiazole → (E)-4-cyclopentyl-2-(4-methanesulfonyl-3-trifluoromethyl-phenyl)-but-2-enoic acid thiazol-2-ylamide
Reaction equation
C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.BrN1C(=O)CCC1=O.[CH:28]1([CH2:33]/[CH:34]=[C:35](\[C:39]2[CH:44]=[CH:43][C:42]([S:45]([CH3:48])(=[O:47])=[O:46])=[C:41]([C:49]([F:52])([F:51])[F:50])[CH:40]=2)/[C:36]([OH:38])=O)[CH2:32][CH2:31][CH2:30][CH2:29]1.[NH2:53][C:54]1[S:55][CH:56]=[CH:57][N:58]=1>C(Cl)Cl>[S:55]1[CH:56]=[CH:57][N:58]=[C:54]1[NH:53][C:36](=[O:38])/[C:35](/[C:39]1[CH:44]=[CH:43][C:42]([S:45]([CH3:48])(=[O:46])=[O:47])=[C:41]([C:49]([F:52])([F:50])[F:51])[CH:40]=1)=[CH:34]/[CH2:33][CH:28]1[CH2:32][CH2:31][CH2:30][CH2:29]1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 0 °C
Procedure
A solution of triphenylphosphine (550 mg, 2.1 mmol) in methylene chloride (25 mL) was cooled to 0° C. and then treated with N-bromosuccinimide (374 mg, 2.1 mmol). The reaction mixture was stirred at 0° C. for 30 min and then treated with a solution of (E)-4-cyclopentyl-2-[4-(methanesulfonyl)-3-(trifluoromethyl)-phenyl)-but-2-enoic acid (395 mg, 1.05 mmol) in methylene chloride (5 mL). The clear solution was stirred for 15 min at 0° C. and then allowed to warm to 25° C. where it was stirred for 1.5 h. The reaction mixture was then treated with 2-aminothiazole (320 mg, 3.2 mmol), and the resulting suspension was stirred at 25° C. over the weekend. The reaction mixture was concentrated in vacuo to remove methylene chloride, and the residue was diluted with ethyl acetate (50 mL) and a 1N aqueous hydrochloric acid solution (50 mL). The two layers were separated, and the aqueous layer was extracted with ethyl acetate (1×30 mL). The combined organic extracts were successively washed with a saturated aqueous sodium bicarbonate solution (2×50 mL) and a saturated aqueous sodium chloride solution (1×100 mL). The organic layer was then dried over anhydrous magnesium sulfate, filtered, and concentrated in vacuo. Biotage chromatography (FLASH 40M, Silica, 1/1 hexanes/ethyl acetate) afforded the (E)-4-cyclopentyl-2-(4-methanesulfonyl-3-trifluoromethyl-phenyl)-but-2-enoic acid thiazol-2-ylamide (77 mg, 16%) as an amorphous solid: EI-HRMS m/e calcd for C20H21F3N2O3S2 (M+) 458.0946, found 458.0946.
Workup
- stirringThe clear solution was stirred for 15 min at 0° C.
- temperatureto warm to 25° C. where it
- stirringwas stirred for 1.5 h
- stirringthe resulting suspension was stirred at 25° C. over the weekend
- concentrationThe reaction mixture was concentrated in vacuo
- customto remove methylene chloride
- additionthe residue was diluted with ethyl acetate (50 mL)
- customThe two layers were separated
- extractionthe aqueous layer was extracted with ethyl acetate (1×30 mL)
- washThe combined organic extracts were successively washed with a saturated aqueous sodium bicarbonate solution (2×50 mL)
- dry with materialThe organic layer was then dried over anhydrous magnesium sulfate
- filtrationfiltered
- concentrationconcentrated in vacuo
Sources & evidence
- ORD record
- ord-9a8b9fa251a541008571054d42f6da7a
- Source dataset
- uspto-grants-2002_03
- Patent number
- US06353111B1
Reaction notes
Loading…